The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
PMV Pharmaceuticals, Inc
PMV Pharmaceuticals, Inc
Mayo Clinic
National Institutes of Health Clinical Center (CC)
Genmab
Seagen Inc.
Tizona Therapeutics, Inc
IDEAYA Biosciences
Eli Lilly and Company
Seagen Inc.
Merck Sharp & Dohme LLC
NuCana plc
Medicenna Therapeutics, Inc.
Carisma Therapeutics Inc
Five Prime Therapeutics, Inc.
Pliant Therapeutics, Inc.
Corvus Pharmaceuticals, Inc.
Xencor, Inc.
Silverback Therapeutics
Incyte Corporation
Incyte Corporation
Incyte Corporation